INTRODUCTION Worldwide appearance of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants of concern (VOCs) with increased transmissibility and resistance to …

Background New approaches for the prevention and elimination of malaria, a leading cause
of illness and death among infants and young children globally, are needed. Methods We …

Background Additional interventions are needed to reduce the morbidity and mortality caused
by malaria. Methods We conducted a two-part, phase 1 clinical trial to assess the safety …

Neutralizing antibody responses gradually wane against several variants of concern (VOCs)
after vaccination with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Influenza vaccines could be improved by platforms inducing cross-reactive immunity.
Immunodominance of the influenza hemagglutinin (HA) head in currently licensed vaccines …

An understanding of the antigen-specific B-cell response to the influenza virus hemagglutinin
(HA) is critical to the development of universal influenza vaccines, but it has not been …

SARS-CoV-2 mRNA booster vaccines provide protection from severe disease, eliciting strong
immunity that is further boosted by previous infection. However, it is unclear whether these …

Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with epithelial-cell
cancers and B cell lymphomas. An effective EBV vaccine is not available. We found that …

Background WHO has identified Marburg virus as an emerging virus requiring urgent vaccine
research and development, particularly due to its recent emergence in Ghana. We report …

Background and Objectives SARS-CoV-2 infection has been associated with a syndrome of
long-term neurologic sequelae that is poorly characterized. We aimed to describe and …